Table 1

Patient characteristics, bowel symptoms, and benefit after biofeedback at follow up

Sex Age Bowel symptoms Disability DSS EDSS ISS-bo ISS-bl CAMBS Benefit at follow up
F26COMild/Moderate2420D1R1P1H1Marked
F28FI and COMild/Moderate3433D2R2P1H3Marked
F38COMild/Moderate2630D2R2P1H2Moderate
F50FI and COMild/Moderate2631D2R1P1H3Moderate
F43FI and COMild/Moderate5444D2R1P1H4Moderate
M27CO and FISevere7222D4R2P3H4Slight
M38CO and FISevere6424D4R3P3H5Slight
F49CO and FISevere6430D3R2P1H3Slight
M35FI and COSevere6644D3R3P2H4Slight
F53CO and FISevere6634D3R4P2H3None
F56CO and FISevere6232D4R3P3H5None
M35COSevere7220D4R3P2H4None
M50COSevere8633D4R3P3H5None
  • DSS=Disability status scale; EDSS=expanded disability status scale for bowel and bladder functions; ISS-bo= incapacity status scale for bowel; ISS-bl=incapacity status scale for bladder; CAMBS=Cambridge multiple sclerosis basic score.

  • Predominant symptom out of constipation (CO) and faecal incontinence (FI) is mentioned first. DSS has a range of 0 (normal neurological examination) to 9 (totally disabled, bed-restricted). EDSS section on bowel and bladder has a range of 0 (normal) to 6 (loss of bowel and bladder function). ISS rates bowel and bladder dysfunction separately, with a range of 0 (normal) to 4 (major incontinence or inability to maintain a stoma without assistance).